CME Group Inc. (CME) — Fair Value Analysis

Base-case fair value (P50): $304.68 · Current price: $269.80 · Verdict: Fairly Valued

The Verdict on CME

CME Group (CME) is currently assessed as Fairly Valued based on our Monte Carlo simulations. With CME trading at $269.80, our median fair value (P50) stands at $304.68, indicating a potential upside of +12.9%. While this suggests some room for growth, the proximity of the current market price to our probabilistic fair value indicates that the market is largely aligned with our fundamental assessment. Our simulations project thousands of forward scenarios, and this P50 figure represents the most likely outcome for CME's intrinsic value, factoring in various market dynamics and company-specific drivers. Investors should consider that this valuation reflects a balanced outlook, with the market pricing in expected performance.

How CME stacks up against Financial Services

Within the Financial Services sector, CME Group holds an average quality tier in terms of its operational and financial health. This assessment reflects its stability and performance relative to its industry peers, without suggesting a significant advantage or disadvantage compared to the sector's top or bottom performers. Our Monte Carlo simulations, which arrive at a median fair value of $304.68 against a $269.80, account for this average quality tier by modeling appropriate financial sensitivities. While CME’s current valuation reflects this solid, albeit not exceptional, standing, it also implies that any substantial shift in its operational or financial profile could influence its future fair value trajectory. The +12.9% from the current price suggests the market is pricing CME consistent with its sector standing.

What this means for investors

For investors considering CME, the 'Fairly Valued' verdict, with a median fair value of $304.68 against the current $269.80, suggests that the stock is neither a clear bargain nor significantly overstretched. The +12.9% potential indicates a modest, rather than substantial, margin of safety or growth opportunity at this juncture. Given CME's average quality tier within Financial Services, its valuation appears rational, reflecting its established market position without anticipating outsized growth or severe underperformance. While a bull case scenario might offer more significant returns, a downside scenario could see its price retract closer to lower probabilistic outcomes. To gain a deeper understanding of these probabilities and the full fair value distribution, including bear and bull case targets, sign up for a free FairCurve account to see the full distribution and track CME's fair value as new fundamentals are released.